In order to support the success of the Covid-19 vaccination program, Universitas Brawijaya through the Covid-19 Prevention Control Task Force held another vaccination campaign. This activity was carried out on Thursday (20/5/2020) via video conference media to the academic community of Universitas Brawijaya
Presented as the speaker, Dr. dr. Gatot Soegiarto, Sp.PD, K.Al, FINASIM, FEEACI, who is a member of the Covid-19 Task Force of East Java Provincial Government. This socialization is aimed at preparing community members who will receive the vaccination injection.
In his presentation, Gatot conveyed how the vaccine works, in this case, the vaccine labeled AstraZeneca. “AstraZeneca works with a non-replicating viral vector concept, which is using an adenovirus which has been partially inactivated. This technique is widely used as gene therapy, ”he said.
This type of vaccine injection is carried out within a period of 8 to 12 weeks after the first injection. Regarding the safety of vaccines, Gatot said that this vaccine is classified as safe.
“The BPOM has received a phase 3 clinical trial report which states that the adverse effects of this type of vaccine are generally mild to moderate. Some of the effects of frequency deviations are quite high, 26 to 63 percent, but none of them experience serious adverse effects, “said the doctor at the Department of Internal Medicine, RSUD dr. Soetomo – Faculty of Medicine, Airlangga University, Surabaya.
“Is this vaccine halal? The use of enzyme trypsin in the process uses enzymes derived from mushrooms, and not from pork. So, MUI Fatwa Commission of East Java Province declares this vaccine is halal or not unclean, ”he added.
With this socialization, both Gatot and UB P3 Task Force hope that the community will take part in the government’s vaccination program, in order to reduce the spread of Covid-19. (VQ/ Humas UB/ Trans. Iir)
